ArticleHepatobiliary surgery and nutrition2013

TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis.

Ping Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.